Mr. Jackson


The 16th edition of the HAI was held in Miami, FL on January 17-19, 2024.



Funding for this conference was made possible, in part by 1 R13 AG042201 from The National Institute on Aging.

The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.



Meilleur Technologies’ mission is to provide technologies, information and related tools to researchers and clinicians in order to improve brain health.


At Lantheus, we Find, Fight and Follow® disease to improve outcomes and lives. We are an established leader in developing, manufacturing, and commercializing pioneering diagnostic and therapeutic products and artificial intelligence (AI) solutions. And our story is one of pioneering, perseverance and partnerships.


The Alzheimer’s Association leads the way to end Alzheimer’s and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.

The Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) is an inclusive global network of scientists, clinicians and dementia professionals. Members of this professional organization share common goals: the pursuit of knowledge, collaboration and breakthroughs to advance the research and treatment of Alzheimer’s disease and other dementias.

Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. 

Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable.




Genentech’s mission is to deliver more life to every patient today and fuel tomorrow’s breakthroughs.


The Eisai Group’s Corporate Concept is “to give first thought to patients and the people in the daily living domain, and to increase the benefits that health care provides to them”. 




The Rainwater Charitable Foundation has a funding program called the Tau Consortium whose mission is to accelerate treatments in a class of neurodegenerative diseases called tauopathies.




BMS is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.



Invicro is an integral part of the REALM IDx, Inc. group, which aims to accelerate personalized medicine, discover novel therapeutic targets and develop innovative therapeutic technologies for unmet medical needs.

Life Molecular Imaging’s mission is to develop novel PET tracers in the field of molecular imaging that improve early detection and characterization of chronic and life-threatening diseases, leading to better therapeutic outcomes and improved quality of life.

Johnson & Johnson Innovative Medicine is leading where medicine is going. Patients inform and inspire our science-based innovations, which continue to change and save lives. With rigorous science and compassion, we confidently address the most complex diseases of our time and unlock the potential medicines of tomorrow. Therapeutic areas include: Oncology, Immunology, Neuroscience, Cardiovascular, Pulmonary Hypertension, and Retina.


C₂N Diagnostics is a molecular diagnostics company aiming to transform the early diagnosis and early treatment of Alzheimer’s disease and related forms of neurodegeneration

At AbbVie, our life’s work is to improve lives, and we pledge to do so in a transparent and sustainable way.

We’re incredibly passionate about the work we are doing, and wholeheartedly believe that we can transform today’s sick care into tomorrow’s precision healthcare through early detection and disease prevention sciences.

Clario is a clinical trial management company that can help improve data and direct research. With 24/7 partner and patient support, along with training and instructions integrated into our devices, our technology and clinical trial management and solutions drive successful adoption, compliance, and retention.